SmPC - Sunitinib Accord 37.5mg hard capsules: Change history
View Summary of Product Characteristics (SmPC - Sunitinib Accord 37.5mg hard capsules)
Last updated on this site: 03 Jun 2025
To update sections 4.4, 4.6, 4.8 and 5.2 of the SmPC in line with the reference product Sutent 12.5 mg, 25 mg, 37.5 mg, 50 mg hard capsules; MAH: Pfizer Europe MA EEIG, Belgium; EU procedure number: EMEA/H/C/000687) and to make minor editorial changes. Consequently, the patient information leaflet has been updated.
View Summary of Product Characteristics (SmPC - Sunitinib Accord 37.5mg hard capsules)
Last updated on this site: 03 Jun 2025
To update sections 4.4, 4.6, 4.8 and 5.2 of the SmPC in line with the reference product Sutent 12.5 mg, 25 mg, 37.5 mg, 50 mg hard capsules; MAH: Pfizer Europe MA EEIG, Belgium; EU procedure number: EMEA/H/C/000687) and to make minor editorial changes. Consequently, the patient information leaflet has been updated.
-
Changes: (Updated: 03 Jun 2025)
To update sections 4.4, 4.6, 4.8 and 5.2 of the SmPC in line with the reference product Sutent 12.5 mg, 25 mg, 37.5 mg, 50 mg hard capsules; MAH: Pfizer Europe MA EEIG, Belgium; EU procedure number: EMEA/H/C/000687) and to make minor editorial changes. Consequently, the patient information leaflet has been updated.
-
Changes: (Updated: 13 Apr 2023)
Initial upload